Digistain
Breast cancer recurrence-risk testing for clinicians treating eligible patients after surgery
Highlights
- New on EvolcAdded 2026-11-14
About Digistain
Digistain provides a quantitative histopathology test that uses optical spectral imaging and a validated statistical model to generate recurrence-risk information for breast cancer patients after surgery. The test runs on routine FFPE tissue sections and supports, but does not replace, clinical judgement.
The test is intended for professional use for invasive breast cancer patients with Stage I–II, HER2-negative, ER-positive disease and up to three positive lymph nodes. Digistain states that results are returned within 1–2 days of specimen receipt at its UK laboratory.
Digistain Limited was founded in 2019 and is headquartered in Newport Pagnell, United Kingdom. Its technology was developed by cancer researchers and physicists from Imperial College London.
Product: A quantitative histopathology test that uses optical spectral imaging and statistical modelling to provide breast cancer recurrence-risk information.
Jobs at Digistain
Leadership
- Hemmel Amrania · Founder / Scientific LeadSource: company website
- James Chandler · Chief Marketing OfficerSource: company website
- Sabrina Ali · Chief Operating OfficerSource: company website
More health & medtech companies
Digital Care AI
Cloud care management software for UK care providers, covering care plans, visit monitoring and CQC and Ofsted compliance reportingYoung companyDigital Prosthetics
Digital dental laboratory producing crowns, implant prostheses and dentures for dental practicesNew on EvolcDigostics
Home oral glucose tolerance testing platforms for healthcare providers screening patients for diabetesNew on EvolcDiligram
Governance software for healthcare organisations to manage policies, training, acknowledgements and audit evidenceDiphex Solutions
Chemical first-aid products and training for workplaces handling hazardous chemicals across the UKNew on EvolcRemote-friendlyDirect Healthcare Group
Medical devices and care services for healthcare providers supporting people with reduced movement
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Marketing & advertising
- LinkedIn InsightMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
